Related Experiment Video
Updated: May 2, 2026
Transcutaneous Microcirculatory Imaging in Preterm Neonates
Published on: December 31, 2015
[Assessment of the hemostatic system in healthy preterm and fullterm newborns]
1Servicio de Hematología, Clínica Universitaria, Facultad de Medicina, Universidad de Navarra.
Insights
Newborns exhibit increased fibrinolytic activity, primarily due to enhanced tissue plasminogen activator (t-PA) and reduced inhibitors. This suggests a balanced hemostatic system in newborns for physiological hemostasis.
Area of Science:
- Hematology
- Neonatal Physiology
- Hemostasis
Context:
- Neonatal hemostasis differs significantly from adults, with near-adult coagulation factor levels achieved by six months.
- Newborns present with impaired platelet aggregation and reduced synthesis of clotting factors and inhibitors.
- Molecular abnormalities in blood coagulation proteins are also observed in newborns.
Purpose:
- To assess the fibrinolytic activity in healthy newborns.
- To understand the role of fibrinolysis in the neonatal hemostatic system.
Summary:
- A study of 100 healthy newborns revealed significantly increased fibrinolytic activity.
- This increase is mainly attributed to enhanced tissue plasminogen activator (t-PA) and decreased levels of fibrinolysis inhibitors.
- The findings indicate a state of equilibrium between the clotting and fibrinolytic systems in newborns, ensuring physiological hemostasis.
Impact:
- Provides crucial insights into the unique hemostatic balance in newborns.
- Highlights the importance of the fibrinolytic system in neonatal physiology.
- May inform clinical management and understanding of bleeding or clotting disorders in neonates.
Abstract:
Assessment of the hemostatic system in premature and newborn infants. When the newborn is compared to older children and adults, several differences in the coagulation and fibrinolytic systems have been described; near-adult values are achieved for most components by 6 months of life. The newborn has an impaired platelet aggregation, reduced synthesis of clotting factors and inhibitors and molecular abnormalities in some proteins of blood coagulation. The role of fibrinolysis is, however, less well known. We have performed a study to assess the fibrinolytic activity in 100 healthy newborns and we have found a marked increase of the fibrinolytic activity, mainly related to an enhancement of plasminogen activators (t-PA) and reduction of fibrinolysis inhibitors, without systemic fibrinolysis. These results would suggest that the fibrinolytic system in the newborn is in equilibrium with the clotting system in order to preserve physiological hemostasis.
More Related Videos
Related Concept Videos
01:05Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
01:24Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:14Fetal Circulation
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
01:30Venous Thrombosis IV: Nursing Management